Patent 10421761 was granted and assigned to Plexxikon Inc. on September, 2019 by the United States Patent and Trademark Office.
Compounds active on protein kinases and methods for regulating protein kinase pathways are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.